If your email program has trouble displaying this email, view as a webpage. Rare Disease Day 2021: FDA Shows Sustained Support of Rare Disease Product Development During the Public Health Emergency Rare Disease Day is a time to reflect on both the progress that has been made, and the work that needs to be done, to advance rare disease treatments. The COVID-19 pandemic has added urgency, because people with rare diseases are among the most vulnerable to COVID-19. The U.S. Food and Drug Administration is committed to supporting development of  treatments for rare diseases.  To recognize Rare Disease Day and engage with the rare disease community, the FDA is holding a virtual public meeting on March 5, 2021. This meeting will bring together stakeholders to highlight strategies that can promote rare disease product development. Additionally, today we are pleased to announce new actions that extend our efforts in this important space.

Stay Connected with U.S. Food and Drug Administration:

SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA